Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Cost Comparison

Pricing analysis for both peptides reflects their investigational status and limited availability through legitimate channels[64]. Research-grade Semax from verified suppliers ranges from $180-320 per 10mg vial, with monthly costs of $240-420 based on typical

This comparison does not assign a generated winner or score.

  • Pricing analysis for both peptides reflects their investigational status and limited availability through legitimate channels[64]. Research-grade Semax from verified suppliers ranges from $180-320 per 10mg vial, with monthly costs of $240-420 based on typical 400-600 mcg daily dosing[65]. Higher-purity pharmaceutical-grade preparations command premium pricing of $350-580 per 10mg vial[66]. International pharmacy sources in Russia and Eastern Europe offer lower costs of $120-200 per month, though importation legality varies by jurisdiction[67].
  • Selank demonstrates similar pricing structures, with research-grade supplies costing $160-280 per 10mg vial[68]. Monthly treatment costs range from $200-360 based on standard 250-500 mcg daily protocols[69]. Pharmaceutical-grade Selank from Russian manufacturers costs $300-480 per 10mg vial when available through international channels[70]. Compounded preparations, where legally permissible, range from $150-250 per month depending on pharmacy markup and preparation complexity[71].
  • Research Grade (10mg)
  • $180-320[65]
  • $160-280[68]
  • Pharmaceutical Grade (10mg)
  • $350-580[66]
  • $300-480[70]
  • Monthly Cost (Standard Dose)
  • $240-420[65]
  • $200-360[69]
  • International Sources
  • $120-200/month[67]
  • $110-180/month[72]
  • Compounded (where legal)
  • $200-350/month[73]
  • $150-250/month[71]
  • Insurance coverage remains unavailable for both peptides due to their investigational status in the United States[74]. Patient assistance programs do not exist, and flexible spending account (FSA) or health savings account (HSA) eligibility is typically denied[75].
More references

Related material

Comparison

Effectiveness Comparison

Clinical efficacy data for Semax derives primarily from Russian studies involving 1,247 patients across multiple indications[23]. In the landmark cognitive enhancement trial (Prot…

View details →
Comparison

Side-by-Side Comparison

Class — FDA Status Research Use Primary Uses neurotrophic signaling, nootropic signaling neuroimmune modulation Administration subcutaneous injection or intranasal Typical Dosing …

View details →
Comparison

selank vs semax

selank vs semax Selank vs Semax: The Ultimate Peptide Comparison Guide for 2025 Imagine having access to two groundbreaking peptides that could revolutionize cognitive enhancement…

View details →